NasdaqGS - Delayed Quote • USD
Elevation Oncology, Inc. (ELEV)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 4:20 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
40,338.0000
40,338.0000
94,549.0000
32,046.0000
17,276.0000
Operating Income
-40,338.0000
-40,338.0000
-94,549.0000
-32,046.0000
-17,276.0000
Other Income Expense
-5,336.0000
-5,336.0000
-506.0000
7.0000
11.0000
Pretax Income
-45,674.0000
-45,674.0000
-95,055.0000
-32,039.0000
-17,265.0000
Tax Provision
30.0000
30.0000
25.0000
--
--
Net Income Common Stockholders
-45,704.0000
-45,704.0000
-95,080.0000
-32,039.0000
-17,265.0000
Diluted NI Available to Com Stockholders
-45,704.0000
-45,704.0000
-95,080.0000
-32,039.0000
-17,265.0000
Basic EPS
-1.34
--
-4.09
-2.64
-1.04
Diluted EPS
-1.34
--
-4.09
-2.64
-1.04
Basic Average Shares
34,077.6750
--
23,267.1200
12,132.6100
16,536.7320
Diluted Average Shares
34,077.6750
--
23,267.1200
12,132.6100
16,536.7320
Total Operating Income as Reported
-45,445.0000
-45,445.0000
-94,549.0000
-32,046.0000
-17,276.0000
Total Expenses
40,338.0000
40,338.0000
94,549.0000
32,046.0000
17,276.0000
Net Income from Continuing & Discontinued Operation
-45,704.0000
-45,704.0000
-95,080.0000
-32,039.0000
-17,265.0000
Normalized Income
-41,669.4700
-41,669.4700
-95,080.0000
-32,039.0000
-17,265.0000
EBIT
-40,338.0000
-40,338.0000
-94,549.0000
-32,046.0000
-17,276.0000
EBITDA
-40,299.0000
-40,299.0000
-94,522.0000
-32,028.0000
-17,261.0000
Reconciled Depreciation
39.0000
39.0000
27.0000
18.0000
15.0000
Net Income from Continuing Operation Net Minority Interest
-45,704.0000
-45,704.0000
-95,080.0000
-32,039.0000
-17,265.0000
Total Unusual Items Excluding Goodwill
-5,107.0000
-5,107.0000
--
--
--
Total Unusual Items
-5,107.0000
-5,107.0000
--
--
--
Normalized EBITDA
-35,192.0000
-35,192.0000
-94,522.0000
-32,028.0000
-17,261.0000
Tax Rate for Calcs
0.0002
0.0002
0.0002
--
--
Tax Effect of Unusual Items
-1,072.4700
-1,072.4700
--
--
--
12/31/2020 - 6/25/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CLSD Clearside Biomedical, Inc.
1.3400
+6.35%
VINC Vincerx Pharma, Inc.
0.7300
-18.59%
INAB IN8bio, Inc.
1.0400
0.00%
CGEM Cullinan Therapeutics, Inc.
25.30
+31.43%
LPTX Leap Therapeutics, Inc.
3.2500
+2.52%
BCAB BioAtla, Inc.
2.5400
+12.89%
ACRV Acrivon Therapeutics, Inc.
8.46
-0.12%
IKNA Ikena Oncology, Inc.
1.3000
-0.76%
RZLT Rezolute, Inc.
2.6600
+2.31%
TARA Protara Therapeutics, Inc.
2.9250
-4.10%